•Presented genomics data from pharmacological intervention with UNC0642, a potent and selective G9a/GLP in SAMP8 mice, a model of Alzheimer's disease can provide insights into promising pharmacological targets. This evidence concerns the gene EHMT2 and Alzheimer disease.